The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Reasoning
The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Cite this ruling
CBP Ruling N303161 (2933595900): The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293359
The tariff classification of 1-(3-Hydroxyphenyl)-Piperazine (MHPP) (CAS 59817-32-2) from France.
The tariff classification of MKC-442 (CAS 149950-60-7) from Japan.
The tariff classification of Guanine (CAS 73-40-5) from China.
The tariff classification of Nefazodone (CAS-83366-66-9) and NefazodoneHydrochloride (CAS-82752-00-6), imported in bulk form, from Italy; andAzithromycin (CAS-83905-01-5), Enalapril (75847-73-3) and Enalapril Maleate(CAS-76095-16-
The tariff classification of 2,6-Diaminopurine (CAS 1904-98-9) from France.